Page 60 - 2018_10-Haematologica-web
P. 60

C.S.G. Mirciov et al.
25. Frazer DM, Wilkins SJ, Becker EM, et al.
Hepcidin expression inversely correlates with the expression of duodenal iron trans- porters and iron absorption in rats. Gastroenterology. 2002;123(3):835-844.
26. Townsend A, Drakesmith H. Role of HFE in iron metabolism, hereditary haemochro- matosis, anaemia of chronic disease, and secondary iron overload. Lancet. 2002;359 (9308):786-790.
27. Muckenthaler MU. How mutant HFE causes hereditary hemochromatosis. Blood. 2014;124 (8):1212-1213.
28. Chen J, Enns CA. Hereditary hemochro- matosis and transferrin receptor 2. Biochim Biophys Acta. 2012;1820(3):256-263.
29. Simpson RJ, Cooper CE, Raja KB, et al. Non- transferrin-bound iron species in the serum of hypotransferrinaemic mice. Biochim Biophys Acta. 1992;1156(1):19-26.
30. Bu JT, Bartnikas TB. The use of hypotrans- ferrinemic mice in studies of iron biology. Biometals. 2015;28(3):473-480.
31. Bartnikas TB, Andrews NC, Fleming MD.
Transferrin is a major determinant of hep- cidin expression in hypotransferrinemic mice. Blood. 2011;117(2):630-637.
32. Raja KB, Pountney DJ, Simpson RJ, Peters TJ. Importance of anemia and transferrin levels in the regulation of intestinal iron absorption in hypotransferrinemic mice. Blood. 1999;94(9):3185-3192.
33. Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ, Andrews NC. The transferrin receptor modulates Hfe-dependent regula- tion of hepcidin expression. Cell Metab. 2008;7(3):205-214.
34. Robb A, Wessling-Resnick M. Regulation of transferrin receptor 2 protein levels by trans- ferrin. Blood. 2004;104(13):4294-4299.
35. Gehrke SG, Kulaksiz H, Herrmann T, et al. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin satura- tion and to non-transferrin-bound iron. Blood. 2003;102(1):371-376.
36. Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, Ganz T. Iron transferrin regu-
lates hepcidin synthesis in primary hepato- cyte culture through hemojuvelin and BMP2/4. Blood. 2007;110(6):2182-2189.
37. Gardenghi S, Ramos P, Marongiu MF, et al. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta-tha- lassemic mice. J Clin Invest. 2010;120(12): 4466-4477.
38. Darshan D, Frazer DM, Wilkins SJ, Anderson GJ. Severe iron deficiency blunts the response of the iron regulatory gene Hamp and pro-inflammatory cytokines to lipopolysaccharide. Haematologica. 2010;95 (10):1660-1667.
39. Huang H, Constante M, Layoun A, Santos MM. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood. 2009;113(15):3593- 3599.
40. Keel SB, Doty R, Liu L, et al. Evidence that the expression of transferrin receptor 1 on erythroid marrow cells mediates hepcidin suppression in the liver. Exp Hematol. 2015;43(6):469-478 e466.
1626
haematologica | 2018; 103(10)


































































































   58   59   60   61   62